Dolby Laboratories offers an undervalued, debt-free premium IP franchise with 90% gross margins, VDP and automotive catalysts, and a probability-weighted five-year value of $108.10.
Overview
Dolby Laboratories is a high-margin, asset-light IP licensor whose Dolby Atmos and Dolby Vision standards are embedded across entertainment hardware, software, content creation, and streaming. **The model is unusually recurring and cash generative:** licensing supplies approximately 93% of revenue, international markets contribute 66%, non-GAAP gross margins are approximately 90%, and non-GAAP operating margins are approximately 34%. The company does not manufacture devices; it licenses implementation and system rights to semiconductor vendors and OEMs, earning royalties as products ship. Q3 FY26 showed transitional weakness, with revenue down 3.34% year over year to $304.995 million, GAAP net income down 37.92% to $28.602 million, and non-GAAP EPS down 11.54% to $0.69, although non-GAAP EPS beat consensus by $0.02. Management maintained FY26 revenue guidance at a narrowed $1.41-$1.44 billion range and forecast Q4 revenue of $362-$392 million, a 23% midpoint increase, helped by Meta and Alibaba VDP agreements. **The valuation case rests on a 19.04x forward P/E, zero long-term debt, approximately $389 million of TTM FCF, and a DCF value of $124 per share versus a $62.41 reference price.** Automotive, wearables, VDP, dividends, and $427 million of buyback capacity are the principal catalysts.